Humacyte, Inc.
General ticker "HUMAW" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $246.1M (TTM average)
Humacyte, Inc. does not follow the US Stock Market performance with the rate: -36.0%.
Estimated limits based on current volatility of 44.3%: low 0.01$, high 0.02$
Factors to consider:
- Total employees count: 184 (-16.4%) as of 2025
- Current price 86.9% below estimated low
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.08$, 0.37$]
- 2026-12-31 to 2027-12-31 estimated range: [0.11$, 0.45$]
Short-term HUMAW quotes
Long-term HUMAW plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $2.04MM |
| Operating Expenses | $100.05MM | $114.40MM | $110.17MM |
| Operating Income | $-100.05MM | $-114.40MM | $-108.14MM |
| Non-Operating Income | $-10.73MM | $-34.30MM | $67.30MM |
| Interest Expense | $6.60MM | $9.28MM | $11.25MM |
| R&D Expense | $76.55MM | $88.60MM | $69.30MM |
| Income(Loss) | $-110.78MM | $-148.70MM | $-40.83MM |
| Net Income(Loss)* | $-110.78MM | $-148.70MM | $-40.83MM |
| Stockholders Equity | $13.55MM | $-52.67MM | $3.11MM |
| Inventory | $0.00MM | $0.00MM | $13.59MM |
| Assets | $128.22MM | $137.87MM | $116.37MM |
| Operating Cash Flow | $-73.31MM | $-98.12MM | $-105.04MM |
| Capital expenditure | $2.28MM | $1.57MM | $0.88MM |
| Investing Cash Flow | $-0.17MM | $-1.57MM | $-0.88MM |
| Financing Cash Flow | $4.51MM | $114.18MM | $61.49MM |
| Earnings Per Share** | $-1.07 | $-1.26 | $-0.26 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.